Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer
Where in Franciaország
- Chambéry · Centre Hospitalier Métropole SavoieIsmeretlen állapot
The registry text, word for word
Prospective Monocentric Study of the Detection of Sarcopenia in Clinical Practice in Patients With Ovarian or Endometrial Cancer Requiring Systemic Oncological Treatment
Prospective monocentric study, non-randomized of the detection of sarcopenia in clinical practice in patients with ovarian or endometrial cancer requiring systemic oncological treatment.
main question : Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria.
Data collection will be done at 6 months, 12 months after the date of inclusion.
Inclusion: Patients at least 18 years old; Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy; Patient with a diagnosis of endometrial cancer with an indication for chemotherapy; Patient with no diagnosis of other types of cancer in the previous five years; Collection of consent; Patient affiliated to a Social Security scheme.
Exclusion: Patient with cancer of ovarian origin not requiring chemotherapy treatment; Patient with endometrial cancer not requiring chemotherapy treatment; Discovery of an intercurrent cancer other than skin or cervix cancers; Patient wearing a Pace maker.